IVD Quality Control Market Regional Analysis

IVD Quality Control Market size was valued at USD 1.11 Billion in 2023 and is poised to grow from USD 1.16 Billion in 2024 to USD 1.56 Billion by 2032, growing at a CAGR of 4.10% during the forecast period (2025-2032).

The Global In Vitro Diagnostics Quality Control market is moderately competitive. Key players adopted various strategies such as merger & acquisitions, collaboration and others to strengthen their position in the global market. Companies focusing on new treatments to produce innovative products. 'Bio-Rad Laboratories', 'Abbott Laboratories', 'Siemens Healthineers', 'Thermo Fisher Scientific', 'Roche Diagnostics', 'Randox Laboratories', 'Bio-Techne Corporation', 'Ortho Clinical Diagnostics', 'Streck', 'Sysmex Corporation', 'Technopath Clinical Diagnostics', 'Helena Biosciences', 'SeraCare Life Sciences', 'Quidel Corporation', 'ZeptoMetrix Corporation', 'Merck KGaA', 'Seracare Life Sciences', 'Fortress Diagnostics', 'Maine Molecular Quality Controls', 'LGC Group'

Burden of various diseases are increased which result in increasing laboratory tests. So that there is an increase in the laboratories in the public and commercial sectors. In Dec2019, COVID-19 increased rapidly which led to high demand for diagnostic testing. Many government authorities have established additional laboratories in order to increase the capacity of laboratory testing. Hence drive the market growth.

Due to increasing prevalence of diseases, medical device companies are continuously focusing on the development of technologically advanced diagnostic devices. Hospitals and laboratories show a rising preference towards point-of-care testing devices to get accurate real time data. Hence the demand for point-of-care testing devices is increased that help to propel the market growth.

North America is expected to hold a large revenue share of the global IVD quality control market due to the presence of the U.S. FDA and many accredited diagnostic laboratories coupled with a strong QC regulation system. The U.S. FDA along with GHTF regulates the North America region for the IVD QC market, from the production to pre-and post-marketing surveillance.